Incyte Newsroom

A Quick Look at Today's Ratings for Incyte(INCY.US), With a Forecast Between $80 to $97

Moomoo NewsOct 31 09:19 ET

Goldman Sachs Maintains Neutral on Incyte, Raises Price Target to $70

BenzingaOct 30 13:05 ET

Incyte Is Maintained at Neutral by JP Morgan

Dow JonesOct 30 12:04 ET

Incyte Price Target Raised to $52.00/Share From $48.00 by BMO Capital

Dow JonesOct 30 10:12 ET

A Quick Look at Today's Ratings for Incyte(INCY.US), With a Forecast Between $48 to $97

Moomoo NewsOct 30 09:14 ET

Argus Adjusts Price Target on Incyte to $80 From $75

MT NewswiresOct 30 08:42 ET

Incyte Analyst Ratings

BenzingaOct 30 07:15 ET

BofA Upgrades Incyte to Buy From Neutral, Adjusts Price Target to $90 From $68

MT NewswiresOct 30 06:08 ET

Wells Fargo Adjusts Price Target on Incyte to $68 From $62, Maintains Equalweight Rating

MT NewswiresOct 29 12:20 ET

Stifel Maintains Incyte(INCY.US) With Hold Rating, Maintains Target Price $73

Moomoo NewsOct 28 08:35 ET

Stifel Nicolaus Sticks to Their Hold Rating for Incyte (INCY)

TipRanksOct 28 07:59 ET

Incyte Is Maintained at Neutral by JP Morgan

Dow JonesOct 23 13:22 ET

Incyte Analyst Ratings

BenzingaOct 23 13:13 ET

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Otsuka Holdings Co (OtherOTSKF) and AngioDynamics (ANGO)

TipRanksOct 23 08:13 ET

TD Cowen Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $80

Moomoo NewsOct 21 08:36 ET

Incyte (INCY) Gets a Buy From TD Cowen

TipRanksOct 21 07:47 ET

Incyte Analyst Ratings

BenzingaOct 10 11:22 ET

Wells Fargo Sticks to Their Hold Rating for Incyte (INCY)

TipRanksOct 10 06:40 ET

Guggenheim Adjusts Price Target on Incyte to $86 From $92

MT NewswiresOct 3 08:47 ET

Incyte Analyst Ratings

BenzingaOct 1 06:07 ET